Market Overview

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB)

0.68 -0.30 (-30.65%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
After-Hours
EPS:
REV:
-0.24
136.032K



Q4 2019
After-Hours
EPS:
REV:
-0.02
119.321K



Q3 2019
After-Hours
EPS:
REV:
-0.02
231.458K



Q2 2019
After-Hours
EPS:
REV:
-0.02
542.127K



Q1 2019
After-Hours
EPS:
REV:
-0.83
276.445K

-0.24
136.032K

Q4 2018
After-Hours
EPS:
REV:
-0.04
395.139K

-0.02
119.321K

Q3 2018
After-Hours
EPS:
REV:
-0.01
223.669K

-0.02
231.458K

Q2 2018
After-Hours
EPS:
REV:
-0.02
611.599K

-0.02
542.127K

Q1 2018
After-Hours
EPS:
REV:
-0.02
580.03K

-0.04
276.445K

Q4 2017
After-Hours
EPS:
REV:
-0.02
3.356M

-0.04
395.139K

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!